What does collective surveillance study?
Collective surveillance observes the distribution of health problems and exposures within a working population. It looks for signs that can help in prevention: symptom clusters, differences between groups, temporal changes, or intervention needs. Its purpose is not to create personal classifications or assign a diagnosis to someone based on their department’s average.
It complements individual monitoring and requires coordination with risk assessment. Royal Decree 843/2011 includes its systematic and continuous implementation among the healthcare activities of occupational health services. It is not enough to simply add a chart of medical examinations to the annual report if that chart does not answer a preventive question.
Define the population and the question
The analysis should begin with a specific question, such as whether more discomfort arises during a particular task or whether the results change after reducing an exposure. Next, the population, time period, and inclusion criteria are defined. It must be clear whether the study includes the entire staff, those who are exposed, or those who participated in a healthcare activity.
These populations may differ. Using only participants in medical examinations without examining who was excluded can introduce bias. It is also important to consider shift changes, temporary hiring, or transfers. A figure without information about the reference population may appear accurate but not allow for a valid comparison.
Sources of information and quality
Relevant health outcomes, exposure history, assessments, and injury records may be used, within applicable competencies and safeguards. Occupational medicine provides the health interpretation and coordinates the analysis with other disciplines. Data must serve a defined purpose and be of sufficient quality and consistency.
It is necessary to check dates, duplicates, definitions, and changes in data collection methods. If symptoms are asked about differently one year, a variation may reflect that change and not a change in risk. The limitations of the registry should also be maintained, rather than equating a lack of information with the absence of disease.
Indicators and denominators
Indicators must specify what they measure and for which population. Existing cases during a period, new cases, and the percentage of people tested describe different aspects. It is not advisable to use the same terminology or to compare figures calculated using incompatible rules across different centers or years .
In small groups, a few cases can significantly alter a percentage. Interpretation should consider size, participation, and differences in exposure. Comparisons may also be affected by age, seniority, or other relevant factors. Presenting the context and uncertainty is preferable to creating a departmental ranking based on differences that have not been studied.
Confidentiality and communication
Health data protection must be designed from the outset. Removing names does not guarantee anonymity if a unique job title, date, and rare diagnosis are combined. Before disseminating results, it is essential to assess whether someone can be directly or indirectly identified and adjust the level of detail accordingly.
The company and its representatives receive aggregated preventive information tailored to their roles. It may be necessary to group categories, extend time periods, or remove breakdowns that could expose individuals. These decisions should maintain as much preventive utility as possible. Individual clinical information remains within the healthcare system with appropriate access and safeguards.
From signal to intervention
A statistical association alone does not prove causation. A signal should prompt a review of plausibility, exposures, and possible explanations, not an automatic conclusion. The prevention team may need to observe tasks, complete measurements, or improve information before determining which intervention is appropriate.
The findings are incorporated into the preventive planning process, assigning responsibilities and implementing follow-up. It is also necessary to verify whether the improvements reach those exposed and whether any unforeseen effects arise. Collective monitoring is valuable when it completes the cycle between information, decision-making, changes in conditions, and evaluation of results.
Practical example
The health service detects a concentration of upper limb discomfort among people performing a particular work operation. It checks the symptom definition, participation, and staff changes. The technical team reviews the task and finds combinations of force, repetition, and insufficient recovery that warrant preventive measures.
Tools and organization are redesigned, and monitoring is established using comparable criteria. The collective report communicates exposures and measures without disclosing medical histories. If discomfort decreases, it is also analyzed whether tasks or the population have changed. The result is interpreted in conjunction with the technical verification that exposure has been reduced.
Common mistakes and review
Common mistakes include using only absenteeism, comparing percentages without denominators, or inferring that an illness is work-related simply because several cases share the same workplace. Collecting data that won’t be used or publishing breakdowns that could identify an individual are also errors. A simple, well-defined analysis is usually more useful than numerous charts lacking interpretation.
The program review should ask what decisions it has enabled, what information is missing, and what measures have been verified. Quality is assessed through its connection to prevention and respect for individuals. Collective activity must be maintained as a health and epidemiological process, not as a tool for monitoring individual performance.
